Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000775611 | SCV000909975 | likely benign | Familial hypercholesterolemia | 2017-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000775611 | SCV001004493 | likely benign | Familial hypercholesterolemia | 2024-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406698 | SCV002715805 | benign | Cardiovascular phenotype | 2022-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003955503 | SCV004769281 | likely benign | LDLR-related disorder | 2024-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |